Lu et.al – “A national survey of hospital‐based transfusion services on their approaches to platelet bacterial risk mitigation in response to the FDA final guidance for industry”

Scroll to Top

Federal mandates may constrain platelet availability even more4,9

The safety of platelet transfusions is critical, and recent US Food and Drug Administration (FDA) mandates on bacterial risk mitigation require platelet collections to undergo proactive safety protocols, such as large volume delayed sampling or pathogen reduction. Platelet volume loss due to methods such as these may further erode the platelet supply.4,9